Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (20)

2024

  1. A translational framework to DELIVER nanomedicines to the clinic

    Nature Nanotechnology

2022

  1. Single Mutation on Trastuzumab Modulates the Stability of Antibody-Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry

    Journal of the American Chemical Society, Vol. 144, Núm. 12, pp. 5284-5294

2017

  1. Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases

    Journal of Cheminformatics, Vol. 9, Núm. 1

2012

  1. Factors associated with health-related quality of life in adults with asthma. A cross-sectional study

    Multidisciplinary Respiratory Medicine, Vol. 7, Núm. 5

  2. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Factors associated with a higher prevalence of work disability among asthmatic patients

    Journal of Asthma, Vol. 48, Núm. 2, pp. 194-199

2010

  1. Factors associated with asthma control in primary care patients: The CHAS study

    Archivos de Bronconeumologia, Vol. 46, Núm. 7, pp. 358-363

1999

  1. Scaleup of a pharmaceutical granulation in planetary mixers

    Pharmaceutical Development and Technology, Vol. 4, Núm. 2, pp. 145-150

1996

  1. A comparison of the wet massing properties of high- and low-density microcrystalline cellulose

    Pharmaceutical Sciences, Vol. 2, Núm. 3, pp. 125-126

  2. Scale-up of a pharmaceutical granulation in fixed bowl mixer-granulators

    International Journal of Pharmaceutics, Vol. 133, Núm. 1-2, pp. 127-131

  3. The effect of batch size on scale-up of a pharmaceutical granulation in a fixed bowl mixer granulator

    International Journal of Pharmaceutics, Vol. 134, Núm. 1-2, pp. 243-246

1995

  1. Characterization of wet powder masses with a mixer torque rheometer. 3. Nonlinear effects of shaft speed and sample weight

    Journal of Pharmaceutical Sciences, Vol. 84, Núm. 5, pp. 557-560

  2. Chemical stability of acetylsalicylic acid in tablets prepared with different particle size fractions of a commercial brand of dicalcium phosphate dihydrate

    International Journal of Pharmaceutics, Vol. 123, Núm. 1, pp. 143-144

1994

  1. Chemical stability of acetylsalicylic acid in tablets prepared with different commercial brands of dicalcium phosphate dihydrate

    International Journal of Pharmaceutics, Vol. 107, Núm. 3, pp. 247-249

  2. Dicalcium phosphate dihydrate for direct compression: Characterization and intermanufacturer variability

    International Journal of Pharmaceutics, Vol. 109, Núm. 1, pp. 1-8

  3. Particle size effects on the dehydration of dicalcium phosphate dihydrate powders

    International Journal of Pharmaceutics, Vol. 104, Núm. 3, pp. 271-275

  4. Structural changes during the dehydration of dicalcium phosphate dihydrate

    European Journal of Pharmaceutical Sciences, Vol. 2, Núm. 3, pp. 245-252

  5. The effect of country of origin on the properties of dicalcium phosphate dihydrate powder

    International Journal of Pharmaceutics, Vol. 103, Núm. 1, pp. 9-18

1993

  1. Interlot variability of carbomer 934

    International Journal of Pharmaceutics, Vol. 100, Núm. 1-3, pp. 207-212

  2. PARTICLE SIZE EFFECTS ON THE DEHYDRATION OF DICALCIUM PHOSPHATE DIHYDRATE

    Pharmacy and Pharmacology Communications, Vol. 45, Núm. 12 S, pp. 1137-1137